Nektar Therapeutics has a robust research and development pipeline in oncology, immunology, and virology. They focus on activating the immune system's tumor-fighting mechanisms, restoring immune balance, and addressing viral infections. The company also has a portfolio of approved partnered medicines. Nektar Therapeutics is headquartered in San Carlos, California, with additional operations in Huntsville, Alabama and Hyderabad, India.